Idorsia reports positive data for paediatric insomnia study of daridorexant
The primary endpoint analysis showed a dose-dependent increase in total sleep time from baseline on day one.
Clinical Trials
Prilenia and Ferrer enrol first participant in PREVAiLS Phase III trial
J&J reports results from ICONIC 52-week trials of Icotyde
Lantern receives FDA clearance for paediatric STAR-001 CNS trial
Viking Therapeutics completes patient enrolment in VANQUISH-2 trial
myTomorrows and CUN partner on AI-assisted patient trial matching
LB Pharmaceuticals commences Phase III schizophrenia trial
C4 Therapeutics begins dosing in Phase Ib trial for multiple myeloma
